MGC in Korean supply deal

Medical cannabis company MGC Pharmaceuticals has locked in a supply agreement that it expects to net about $20 million in annual revenue.

Perth-based MGC said today it had executed a binding terms and conditions supply agreement for white-label cannabinoid oil cosmetics products to South Korean cosmetics manufacturer Varm Cosmo.

The agreement was made through MGC subsidiary MGC Derma, of which it owns 51 per cent.


(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 7 articles per month + twice daily business email alerts.

Thanks! This question prevents spammers...
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer